Apolipoprotein CIII Antibody Human | 552-33A-G2a
Species Reactivity Human, Rat
Host/Isotype Rabbit / IgG
Class Recombinant Polyclonal
Type Antibody
Clone 6HCLC
Immunogen Peptide corresponding to amino acids 37–48 of human Apolipoprotein C3
Conjugate Unconjugated
Form Liquid
Concentration 0.5 mg/mL
Purification Protein A
Storage buffer PBS
Contains 0.09% sodium azide
Storage conditions Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
RRID AB_2532651
Product Specific Information
This antibody is predicted to react with mouse, non-human primate, rabbit and porcine based on sequence homology.
Recombinant rabbit polyclonal antibodies are unique offerings from Thermo Fisher Scientific. They are comprised of a selection of multiple different recombinant monoclonal antibodies, providing the best of both worlds - the sensitivity of polyclonal antibodies with the specificity of monoclonal antibodies - all delivered with the consistency only found in a recombinant antibody.
While functionally the same as a polyclonal antibody - recognizing multiple epitope sites on the target and producing higher detection sensitivity for low abundance targets - a recombinant rabbit polyclonal antibody has a known mixture of light and heavy chains. The exact population can be produced in every lot, circumventing the biological variability typically associated with polyclonal antibody production.
Target Information
Apolipoprotein C-III, also known as apo-CIII, is a protein that in humans is encoded by the APOC3 gene. Apo-CIII is a component of very low density lipoprotein (VLDL). APOC3 inhibits lipoprotein lipase and hepatic lipase; it is thought to delay catabolism of triglyceride-rich particles.
The APOA1, APOC3 and APOA4 genes are closely linked in both rat and human genomes. The A-I and A-IV genes are transcribed from the same strand, while the A-1 and C-III genes are convergently transcribed. An increase in apoC-III levels induces the development of hypertriglyceridemia.
